New research published online in June in the journal "Nature Medicine" finds that the TNF inhibitor etanercept (Enbrel) may offer treatment and hope to people with autosomal dominant polycystic kidney disease (ADPKD). ADPKD is a genetically inherited renal disease that affects about 1 in 800 people. The disease causes the kidneys to develop cysts and since there are no treatments currently available to prevent the cysts, ADPKD can eventually lead to end stage renal...
Tnf Inhibitors Etanercept
Featured Health Expert
More information on "Tnf Inhibitors Etanercept"
From Our Experts
EXPERT
TNF inhibitors may slightly increase risk for skin cancer
By Christine Miller, Health Expert
Tumor necrosis factor inhibitors such as etanercept (Enbrel) or infliximab (Remicade) are some of the newest and most expensive drugs... Read more »
EXPERT
Anti-TNF Inhibitor Therapy May Provide Long Lasting Relief for RA:...
By Christine Miller, Health Expert
Earlier in November, the American College of Rheumatology held its 71st annual scientific meeting. Among the many research studies... Read more »
EXPERT
RA: TNF-inhibitor-methotrexate Therapy is Associated with Reduction...
By Christine Miller, Health Expert
After writing the other week about the depressing research related to mortality rates of RA sufferers and the link to cardiovascular... Read more »
EXPERT
New FDA Warnings for TNF Inhibitors- What are the Fungal Diseases...
By Christine Miller, Health Expert
What are the warnings? The U.S. Food and Drug Administration just announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade... Read more »
EXPERT
European Study Finds TNF Inhibitors Effective in Treating RA
By Mark Borigini, M.D., Health Expert
The recent meeting of the European League Against Rheumatism (EULAR) continued to present more data on the tumor necrosis factor (TNF)... Read more »
From Our Sources
TNF drugs work well against RA: study
According to a new study, recently diagnosed rheumatoid arthritis patients who do respond to methotrexate respond well to TNF blocker drugs such as... Read more »
TNF-blocker drugs may boost tuberculosis risk
New research published in the journal Arthritis & Rheumatism suggests that the anti-TNF drugs used to treat rheumatoid arthritis, Crohn's... Read more »
TNF blockers do not boost cancer risk: study
An analysis of previous studies has found that treatment with tumor necrosis factor (TNF) blockers does not increase rheumatoid arthritis (RA)... Read more »
Experts: Anti-TNF meds may boost infection risk
Medications used to treat such conditions as rheumatoid arthritis (RA) and inflammatory bowel disease may boost patients' risk of infection, experts... Read more »
Study: TNF blockers don't prevent RA's progress
A recent study in the United Kingdom suggests that short-term treatment with tumor necrosis factor (TNF) blocking medications eases the symptoms of... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
